Sandoz, a member of the Novartis Group and the second largest generic drug company in the world, produces and provides products of international quality and affordable prices, which are exported to more than 130 countries.
The history of Sandoz can be traced back to 1886, when Dr. Alfred Kern and Edouard Sandoz established the chemical company Kern & Sandoz in Basel, Switzerland, the predecessor of today's Sandoz. In 1996, Sandoz and Ciba-Geigy merged to form Novartis. In 2003, Novartis Group unified all generic drug businesses under the unified global brand Sandoz.
Today, Sandoz has become a leader in the global generic drug industry. In 2008, Sandoz’s global sales reached US$7.6 billion. It has more than 23,000 employees worldwide and operates in the 15 largest countries. Ten companies in the market are in the leading position, and their main business covers APIs, preparations and biological preparations. The main product series include antibiotics, drugs for the treatment of central nervous system disorders, gastrointestinal tract, cardiovascular diseases and hormone therapy drugs. Sandoz has 8 major R&D centers and a strong global production network and technology center around the world. In 2006, with its high-end development and production technology, Sandoz became the first pharmaceutical company to launch biosimilars in Europe and the United States.
In January 2007, Sandoz officially launched its business in China. It is headquartered in Shanghai and has approximately 400 employees. The production base in China is located in the National Health Technology Industrial Base in Zhongshan City, Guangdong Province, covering an area of ??50,000 square meters, with modern production and packaging equipment and a complete quality system. Sandoz's main products in China include Sandoz (octreotide), Sanol (octreotide), Sonitide (isosorbide mononitrate), Diclofenac (diclofenac sodium), Amprexol (ambroxol hydrochloride), Lycopene Deyi (Amoxicillin and Clavulanate Potassium), Jinsiping (Selegiline Hydrochloride), PePP Sober Chewable Tablets, Herning (Somatostatin Acetate), etc.
Sandoz China's vision is to "root in China and benefit thousands of families", and is committed to providing high-quality, reasonably priced products to a wider range of patients, and becoming the first choice of Chinese doctors, pharmacists and patients!
Consumer Healthcare
Novartis' Consumer Healthcare division creates, develops and manufactures a range of innovative, competitive products that restore, maintain or enhance the health and well-being of consumers. Strong and differentiated products.
Shanghai Novartis Animal Health
Our purpose: to save, extend and improve the lives of animals
Novartis Animal Health is part of the Swiss Novartis Group. Develop new treatment methods and technologies to provide professional solutions to animal diseases. At Novartis Animal Health, we invest heavily in human and material resources and focus on developing new drugs to improve the quality of life of animals, improve the health of livestock, poultry and farmed fish, and contribute to the world's high-quality food supply.
We have the foresight to make long-term plans for business development. Our frontline staff visit veterinarians and livestock farmers across the country and work side by side with our customers to help them get the best care for the animals in their care.
Novartis Animal Health is pleased to work with you to continue to provide innovative solutions for animal health.
Shanghai Novartis Animal Health Co., Ltd. is a joint venture of the Swiss company Novartis in China. Its production base is located in the May Fourth Farm in Fengxian, Shanghai, with a total investment of US$30 million. In 1997, it became the first veterinary drug company to obtain a GMP certificate from the Ministry of Agriculture of China. Passed ISO14001 certification in 2004. Won the title of "Advanced Technology Enterprise" in Shanghai for 12 consecutive years.
The company has been committed to promoting the healthy development of China's animal husbandry industry by providing high-quality products and leading services. The company's products are not only sold well in China's domestic veterinary drug market, but are also directly exported to Southeast Asia, South America, Australia and other countries. and region. The main products include Zhiyuanjing, Kangshumi, Fubenkang, Shanzi, Yingdejing, Aijite, etc.
Advanced production facilities, strict quality control, and leading environmental protection and safety concepts are the guarantee for the high-efficiency, low-toxic and high-quality products we provide; our well-trained technical team and perfect service system are the guarantee we provide. Complete solutions provided by customers.